Bio

Academic Appointments


Teaching

2013-14 Courses


Publications

Journal Articles


  • Ethics and embryonic stem cell research - Altered nuclear transfer as a way forward BIODRUGS Hurlbut, W. B. 2007; 21 (2): 79-83

    Abstract

    Ethical controversy in stem cell research arises because current methods to produce embryonic stem cell lines require the destruction of living human embryos. For this reason, there is increasing interest in developing alternative, non-embryonic sources of pluripotent stem cells. This effort is especially important in the US due to the prevailing policy against federal funding of embryo-destructive research. Altered nuclear transfer (ANT) is one of several potential methods to develop alternative sources of pluripotent stem cells. This approach employs the technique of somatic cell nuclear transfer, but the somatic cell nucleus or egg cytoplasm (or both) are first altered before the somatic cell nucleus is transferred into the oocyte. This alteration precludes the coordinated organization and developmental potential that is necessary for the resulting biological entity to be an embryo, but it still allows the entity to generate pluripotent stem cells. Proof-of-principle for one variant of ANT has been established in mice by silencing the functional expression of the gene Cdx2 in the somatic cell nucleus prior to its transfer into an enucleated egg. From the resulting non-embryonic laboratory construct, fully functional pluripotent stem cells were procured. Other more recent studies have suggested the possibility of achieving the same results by preemptively silencing maternally derived Cdx2 messenger RNA in the egg before the act of nuclear transfer. The procedure would produce the equivalent of a tissue culture of pluripotent stem cells. In contrast to the use of embryos 'left over' from clinical in vitro fertilization, ANT could produce pluripotent stem cell lines with an unlimited range of specifically selected and controlled genotypes. Such flexibility would greatly facilitate the study of disease, drug development, and toxicology testing, and may allow the production of therapeutically useful pluripotent stem cells that are immune-compatible. If developed to the point of scientific reliability, ANT would be a valuable research tool for the study of other aspects of cell development and differentiation, including gene expression patterns, imprinting, and cell-cell signaling. ANT would also help to clarify definitions and boundaries that distinguish true organisms from 'biological artifacts' and, thereby, provide moral precedent to guide future progress in developmental biology.

    View details for Web of Science ID 000246260200003

    View details for PubMedID 17402791

  • Seeking consensus: A clarification and defense of altered nuclear transfer HASTINGS CENTER REPORT Hurlbut, W. B., George, R. P., Grompe, M. 2006; 36 (5): 42-50

    View details for Web of Science ID 000241506100021

    View details for PubMedID 17091701

  • Framing the future: Embryonic stem cells, ethics and the emerging era of developmental biology PEDIATRIC RESEARCH Hurlbut, W. B. 2006; 59 (4): 4R-12R

    Abstract

    Throughout the 20(th) century, advances in biology were accomplished largely through the study of biochemical parts apart from their place within the whole organism. This reductive and analytic approach, which has culminated in the sequencing of the human genome, has now led us back to the study of living beings. When applied to human biology, this inquiry re-opens the most fundamental questions concerning the moral meaning of developing life. The current conflict over ES (embryonic stem) cell research is just the first in a series of difficult controversies that will require us to clearly and precisely define the boundaries of humanity that we seek to defend. Through a careful consideration of the social, political, and scientific foundations of our current debate, we may discern the terms of a possible resolution that can sustain social consensus while opening avenues for scientific advance. Four such proposals were discussed in a May 2005 publication by the President's Council on Bioethics, entitled "Alternative Sources of Pluripotent Stem Cells." One of these methods, altered nuclear transfer, proposes to use the technology of somatic cell nuclear transfer (SCNT), but with a pre-emptive genetic or epigenetic alteration that precludes the integrated and coordinated organization essential for natural embryogenesis. The moral and scientific dimensions of this proposal are discussed as a way forward for embryonic stem cell research as well as a frame for further studies in developmental biology.

    View details for DOI 10.1203/01.pdr.0000205377.04359.3e

    View details for Web of Science ID 000236359600002

    View details for PubMedID 16549542

  • Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells PERSPECTIVES IN BIOLOGY AND MEDICINE Hurlbut, W. B. 2005; 48 (2): 211-228

    View details for Web of Science ID 000228807900006

    View details for PubMedID 15834194

  • Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells. The national Catholic bioethics quarterly Hurlbut, W. B. 2005; 5 (1): 145-151

    View details for PubMedID 15887345

  • Patenting humans: Clones, chimeras, and biological artifacts SCIENCE AND ENGINEERING ETHICS Hurlbut, W. B. 2005; 11 (1): 21-29

    Abstract

    The momentum of advances in biology is evident in the history of patents on life forms. As we proceed forward with greater understanding and technological control of developmental biology there will be many new and challenging dilemmas related to patenting of human parts and partial trajectories of human development. These dilemmas are already evident in the current conflict over the moral status of the early human embryo. In this essay, recent evidence from embryological studies is considered and the unbroken continuity of organismal development initiated at fertilization is asserted as clear and reasonable grounds for moral standing. Within this frame of analysis, it is proposed that through a technique of Altered Nuclear Transfer, non-organismal entities might be created from which embryonic stem cells could be morally procured. Criteria for patenting of such non-organismal entities are considered.

    View details for Web of Science ID 000226839800005

    View details for PubMedID 15726996

  • Altered nuclear transfer - A way forward for embryonic stem cell research STEM CELL REVIEWS Hurlbut, W. B. 2005; 1 (4): 293-300

    Abstract

    The present conflict over the moral status of the human embryo reflects deep differences in our basic convictions and is unlikely to be resolved through deliberation or debate. While there are currently no federally legislated constraints on the use of private funds for this research, there is a consensus opinion in the scientific community that without NIH support for newly created embryonic stem cell lines, progress in this important realm of research will be severely constrained. A May, 2005, report by the President's Council on Bioethics, "Alternative Sources of Pluripotent Stem Cells," outlines several proposals for obtaining pluripotent stem cells without the destruction of human embryos. One of these methods, Altered Nuclear Transfer, proposes to use the technology of somatic cell nuclear transfer (SCNT), but with a preemptive genetic or epigenetic alteration that precludes the integrated and coordinated organization essential for natural embryogenesis. Drawing on insights from systems biology, the distinction between totipotency (capacity to form a whole organism) and pluripotency (capacity to form all the cell types) is explored. The implications of this distinction are used to discuss the moral arguments for the inviolability of nascent human life and the moral standing of entities with only partial and unorganized developmental potential. Away forward is proposed that may open positive avenues of advance in both stem cell research and a broader arena of research in developmental biology.

    View details for Web of Science ID 000240469000004

    View details for PubMedID 17142870

Stanford Medicine Resources: